Identification of CD4(+) T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system of autoimmune etiopathogenesis, and is characterized by various neurological symptoms. Glatiramer acetate and interferon-β are administered as first-line treatments for this disease. In non-responsive patients, s...

Full description

Saved in:
Bibliographic Details
Published in:Mol Med Rep
Main Authors: Fagone, Paolo, Mazzon, Emanuela, Mammana, Santa, Di Marco, Roberto, Spinasanta, Flaminia, Basile, Maria Sofia, Petralia, Maria Cristina, Bramanti, Placido, Nicoletti, Ferdinando, Mangano, Katia
Format: Artigo
Language:Inglês
Published: D.A. Spandidos 2019
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6580020/
https://ncbi.nlm.nih.gov/pubmed/31180553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2019.10283
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items